Cargando…
Can subtle changes in gene expression be consistently detected with different microarray platforms?
BACKGROUND: The comparability of gene expression data generated with different microarray platforms is still a matter of concern. Here we address the performance and the overlap in the detection of differentially expressed genes for five different microarray platforms in a challenging biological con...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2335120/ https://www.ncbi.nlm.nih.gov/pubmed/18331641 http://dx.doi.org/10.1186/1471-2164-9-124 |
_version_ | 1782152812890685440 |
---|---|
author | Pedotti, Paola 't Hoen, Peter AC Vreugdenhil, Erno Schenk, Geert J Vossen, Rolf HAM Ariyurek, Yavuz de Hollander, Mattias Kuiper, Rowan van Ommen, Gertjan JB den Dunnen, Johan T Boer, Judith M de Menezes, Renée X |
author_facet | Pedotti, Paola 't Hoen, Peter AC Vreugdenhil, Erno Schenk, Geert J Vossen, Rolf HAM Ariyurek, Yavuz de Hollander, Mattias Kuiper, Rowan van Ommen, Gertjan JB den Dunnen, Johan T Boer, Judith M de Menezes, Renée X |
author_sort | Pedotti, Paola |
collection | PubMed |
description | BACKGROUND: The comparability of gene expression data generated with different microarray platforms is still a matter of concern. Here we address the performance and the overlap in the detection of differentially expressed genes for five different microarray platforms in a challenging biological context where differences in gene expression are few and subtle. RESULTS: Gene expression profiles in the hippocampus of five wild-type and five transgenic δC-doublecortin-like kinase mice were evaluated with five microarray platforms: Applied Biosystems, Affymetrix, Agilent, Illumina, LGTC home-spotted arrays. Using a fixed false discovery rate of 10% we detected surprising differences between the number of differentially expressed genes per platform. Four genes were selected by ABI, 130 by Affymetrix, 3,051 by Agilent, 54 by Illumina, and 13 by LGTC. Two genes were found significantly differentially expressed by all platforms and the four genes identified by the ABI platform were found by at least three other platforms. Quantitative RT-PCR analysis confirmed 20 out of 28 of the genes detected by two or more platforms and 8 out of 15 of the genes detected by Agilent only. We observed improved correlations between platforms when ranking the genes based on the significance level than with a fixed statistical cut-off. We demonstrate significant overlap in the affected gene sets identified by the different platforms, although biological processes were represented by only partially overlapping sets of genes. Aberrances in GABA-ergic signalling in the transgenic mice were consistently found by all platforms. CONCLUSION: The different microarray platforms give partially complementary views on biological processes affected. Our data indicate that when analyzing samples with only subtle differences in gene expression the use of two different platforms might be more attractive than increasing the number of replicates. Commercial two-color platforms seem to have higher power for finding differentially expressed genes between groups with small differences in expression. |
format | Text |
id | pubmed-2335120 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-23351202008-04-25 Can subtle changes in gene expression be consistently detected with different microarray platforms? Pedotti, Paola 't Hoen, Peter AC Vreugdenhil, Erno Schenk, Geert J Vossen, Rolf HAM Ariyurek, Yavuz de Hollander, Mattias Kuiper, Rowan van Ommen, Gertjan JB den Dunnen, Johan T Boer, Judith M de Menezes, Renée X BMC Genomics Research Article BACKGROUND: The comparability of gene expression data generated with different microarray platforms is still a matter of concern. Here we address the performance and the overlap in the detection of differentially expressed genes for five different microarray platforms in a challenging biological context where differences in gene expression are few and subtle. RESULTS: Gene expression profiles in the hippocampus of five wild-type and five transgenic δC-doublecortin-like kinase mice were evaluated with five microarray platforms: Applied Biosystems, Affymetrix, Agilent, Illumina, LGTC home-spotted arrays. Using a fixed false discovery rate of 10% we detected surprising differences between the number of differentially expressed genes per platform. Four genes were selected by ABI, 130 by Affymetrix, 3,051 by Agilent, 54 by Illumina, and 13 by LGTC. Two genes were found significantly differentially expressed by all platforms and the four genes identified by the ABI platform were found by at least three other platforms. Quantitative RT-PCR analysis confirmed 20 out of 28 of the genes detected by two or more platforms and 8 out of 15 of the genes detected by Agilent only. We observed improved correlations between platforms when ranking the genes based on the significance level than with a fixed statistical cut-off. We demonstrate significant overlap in the affected gene sets identified by the different platforms, although biological processes were represented by only partially overlapping sets of genes. Aberrances in GABA-ergic signalling in the transgenic mice were consistently found by all platforms. CONCLUSION: The different microarray platforms give partially complementary views on biological processes affected. Our data indicate that when analyzing samples with only subtle differences in gene expression the use of two different platforms might be more attractive than increasing the number of replicates. Commercial two-color platforms seem to have higher power for finding differentially expressed genes between groups with small differences in expression. BioMed Central 2008-03-10 /pmc/articles/PMC2335120/ /pubmed/18331641 http://dx.doi.org/10.1186/1471-2164-9-124 Text en Copyright © 2008 Pedotti et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Pedotti, Paola 't Hoen, Peter AC Vreugdenhil, Erno Schenk, Geert J Vossen, Rolf HAM Ariyurek, Yavuz de Hollander, Mattias Kuiper, Rowan van Ommen, Gertjan JB den Dunnen, Johan T Boer, Judith M de Menezes, Renée X Can subtle changes in gene expression be consistently detected with different microarray platforms? |
title | Can subtle changes in gene expression be consistently detected with different microarray platforms? |
title_full | Can subtle changes in gene expression be consistently detected with different microarray platforms? |
title_fullStr | Can subtle changes in gene expression be consistently detected with different microarray platforms? |
title_full_unstemmed | Can subtle changes in gene expression be consistently detected with different microarray platforms? |
title_short | Can subtle changes in gene expression be consistently detected with different microarray platforms? |
title_sort | can subtle changes in gene expression be consistently detected with different microarray platforms? |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2335120/ https://www.ncbi.nlm.nih.gov/pubmed/18331641 http://dx.doi.org/10.1186/1471-2164-9-124 |
work_keys_str_mv | AT pedottipaola cansubtlechangesingeneexpressionbeconsistentlydetectedwithdifferentmicroarrayplatforms AT thoenpeterac cansubtlechangesingeneexpressionbeconsistentlydetectedwithdifferentmicroarrayplatforms AT vreugdenhilerno cansubtlechangesingeneexpressionbeconsistentlydetectedwithdifferentmicroarrayplatforms AT schenkgeertj cansubtlechangesingeneexpressionbeconsistentlydetectedwithdifferentmicroarrayplatforms AT vossenrolfham cansubtlechangesingeneexpressionbeconsistentlydetectedwithdifferentmicroarrayplatforms AT ariyurekyavuz cansubtlechangesingeneexpressionbeconsistentlydetectedwithdifferentmicroarrayplatforms AT dehollandermattias cansubtlechangesingeneexpressionbeconsistentlydetectedwithdifferentmicroarrayplatforms AT kuiperrowan cansubtlechangesingeneexpressionbeconsistentlydetectedwithdifferentmicroarrayplatforms AT vanommengertjanjb cansubtlechangesingeneexpressionbeconsistentlydetectedwithdifferentmicroarrayplatforms AT dendunnenjohant cansubtlechangesingeneexpressionbeconsistentlydetectedwithdifferentmicroarrayplatforms AT boerjudithm cansubtlechangesingeneexpressionbeconsistentlydetectedwithdifferentmicroarrayplatforms AT demenezesreneex cansubtlechangesingeneexpressionbeconsistentlydetectedwithdifferentmicroarrayplatforms |